Drug company GlaxoSmithKline to pay £475m over adulterated drug claims
The drug company GlaxoSmithKline PLC will pay £475m to settle allegations that it knowingly manufactured and sold adulterated drugs, federal prosecutors in the US said yesterday.
Read more on Daily Mail
Orignal From: Drug company GlaxoSmithKline to pay £475m over adulterated drug claims
Post a Comment